Rassoul Dinarvand Selected Research

methotrexate-serum albumin

9/2012	Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
7/2012	The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
12/2011	Targeted delivery of methotrexate to tumor cells using biotin functionalized methotrexate-human serum albumin conjugated nanoparticles.
1/2011	Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.
1/2011	Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rassoul Dinarvand Research Topics

Disease

56	Neoplasms (Cancer) 01/2022 - 05/2008
20	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2009
10	Wounds and Injuries (Trauma) 06/2021 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 12/2013
4	Choroidal Neovascularization 01/2020 - 11/2013
4	Inflammation (Inflammations) 12/2019 - 08/2013
4	Alzheimer Disease (Alzheimer's Disease) 12/2018 - 12/2013
4	Colonic Neoplasms (Colon Cancer) 06/2017 - 01/2014
3	Retinoblastoma (Glioblastoma, Retinal) 04/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 10/2019 - 01/2016
3	Drug-Related Side Effects and Adverse Reactions 12/2018 - 01/2011
3	Ischemic Stroke 01/2018 - 06/2017
2	Acne Vulgaris 08/2022 - 01/2018
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 06/2017
2	Glioblastoma (Glioblastoma Multiforme) 06/2021 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 05/2016
2	Rheumatoid Arthritis 01/2020 - 05/2013
2	Disease Progression 11/2019 - 06/2013
2	Burns 01/2019 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 12/2017
2	Cicatrix (Scar) 01/2018 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 01/2014
2	Colitis 06/2017 - 10/2012
2	Necrosis 06/2017 - 08/2014
2	Adenocarcinoma 01/2016 - 05/2015
2	Uveitis 08/2013 - 05/2013
1	COVID-19 06/2022

Drug/Important Bio-Agent (IBA)

32	Pharmaceutical PreparationsIBA 01/2022 - 05/2008
17	ChitosanIBA 04/2022 - 10/2010
12	Docetaxel (Taxotere)FDA Link 04/2021 - 08/2009
6	LipidsIBA 08/2022 - 12/2017
6	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 06/2010
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2008
6	Human Serum Albumin FDA LinkGeneric 12/2016 - 07/2013
5	AntigensIBA 06/2022 - 01/2011
5	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2013
5	Polylactic Acid-Polyglycolic Acid CopolymerIBA 04/2021 - 01/2011
5	PolymersIBA 05/2018 - 10/2014
5	Irinotecan (Camptosar)FDA LinkGeneric 12/2017 - 06/2010
5	Hyaluronic Acid (Hyaluronan)IBA 06/2017 - 06/2014
5	AlbuminsIBA 12/2016 - 08/2009
5	methotrexate-serum albuminIBA 09/2012 - 01/2011
4	Peptides (Polypeptides)IBA 01/2022 - 01/2008
4	Gemcitabine FDA Link 11/2020 - 01/2016
4	Biological ProductsIBA 03/2020 - 10/2014
4	MicroRNAs (MicroRNA)IBA 12/2018 - 11/2015
4	Drug CarriersIBA 05/2018 - 07/2013
4	Biotin (Vitamin H)FDA Link 05/2017 - 01/2011
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2016 - 10/2010
3	Liposomes (Liposome)IBA 01/2022 - 03/2020
3	Sirolimus (Rapamycin)FDA Link 01/2022 - 08/2016
3	Therapeutic UsesIBA 01/2022 - 06/2017
3	LigandsIBA 04/2021 - 01/2011
3	Fibroins (Fibroin)IBA 01/2021 - 10/2014
3	Retinaldehyde (Retinal)IBA 12/2019 - 11/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 12/2017
3	Bevacizumab (Avastin)FDA Link 01/2018 - 11/2013
3	Amyloid beta-PeptidesIBA 01/2018 - 12/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2017 - 01/2016
3	GoldIBA 06/2017 - 07/2016
3	HydrogelsIBA 01/2017 - 01/2016
3	IronIBA 09/2016 - 12/2013
3	Trastuzumab (Herceptin)FDA Link 03/2015 - 01/2011
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 07/2012 - 01/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2022 - 01/2018
2	PorphyrinsIBA 08/2022 - 01/2018
2	carboxymethyl dextranIBA 04/2022 - 01/2022
2	graphene oxideIBA 08/2021 - 01/2018
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 04/2021 - 04/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2015
2	PolyethyleneimineIBA 01/2021 - 11/2013
2	ProdrugsIBA 11/2020 - 01/2017
2	maleimideIBA 06/2020 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2015
2	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 10/2017
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2018 - 12/2017
2	ferulic acid (sodium ferulate)IBA 01/2018 - 06/2017
2	Oxygen (Dioxygen)IBA 01/2018 - 12/2017
2	cabazitaxel FDA Link 11/2017 - 01/2017
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2017 - 05/2016
2	AntioxidantsIBA 06/2017 - 08/2014
2	Sulfonic AcidsIBA 06/2017 - 10/2012
2	Carbon Nanotubes (Carbon Nanotube)IBA 06/2017 - 06/2017
2	DNA (Deoxyribonucleic Acid)IBA 05/2017 - 05/2008
2	biotin receptorIBA 05/2017 - 01/2016
2	Polyglactin 910IBA 04/2016 - 01/2011
2	Deferasirox FDA Link 11/2015 - 12/2013
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 08/2013 - 05/2013
2	Methotrexate (Mexate)FDA LinkGeneric 05/2013 - 12/2011
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 07/2012 - 01/2011

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2010
8	Drug Therapy (Chemotherapy) 01/2022 - 12/2011
4	Photothermal Therapy 01/2018 - 01/2016
3	Lasers (Laser) 01/2020 - 01/2016
3	Precision Medicine 10/2019 - 07/2016
3	Aftercare (After-Treatment) 01/2019 - 01/2011
2	Immunotherapy 01/2020 - 10/2017
2	Intravitreal Injections 01/2020 - 08/2013
2	Topical Administration 05/2016 - 01/2016